Cannabis Entity and Estimated Taxes: The C Corporation Many Operators Choose, the Property Company, and the Quarter You Pay Tax on Profit You Never Saw

For a cannabis business still under Section 280E — an adult-use (recreational) operator, or any operator looking back at a year before 2026 — entity choice is a 280E problem before it is anything else. A pass-through operator's owners are taxed on gross profit — the sales floor's rent and payroll included — at individual rates up to 37 percent, on cash that was spent running the store. A C corporation pays 21 percent on the same inflated base and taxes the owners only on dividends actually paid. That difference, and the ability to move assets into companies the rule does not reach, drives many structures in the industry. Since April 28, 2026, marijuana subject to a state medical marijuana license has been in Schedule III and outside 280E, so a medical-only operator — every Florida treatment center among them — is expected to choose its entity on ordinary terms from its 2026 tax year.

The pass-through problem

| Structure | Federal tax on 280E income | Owner's exposure | |---|---|---| | Sole proprietorship or partnership | Owners taxed at up to 37 percent on gross profit, plus self-employment tax on a sole proprietor's or general partner's share | Tax on income never distributed; no basis for it in cash | | S corporation | Owners taxed at up to 37 percent on gross profit; no self-employment tax on distributions | Same phantom income; reasonable salary is nondeductible except the inventory share | | C corporation | 21 percent on gross profit at the corporate level; 5.5 percent Florida | Owners taxed only on dividends; cash can be retained |

The C corporation's double tax is real — dividends are taxed again — but a 280E business rarely has the cash to pay large dividends, so the second layer stays small. The accumulated earnings tax is a theoretical concern that documented working-capital needs often answer.

The companies outside 280E

Operators under 280E separate what they can:

• Real estate in an LLC that leases the dispensary or grow facility at market rent; the LLC deducts its costs normally and the operator's rent, though nondeductible to it, funds a deductible business.
• Equipment in a leasing company that rents grow lights, extraction equipment, and vehicles to the operator.
• Intellectual property — brands, formulations, processes — in a licensing company that charges royalties.
• Management services in a company that employs administrative staff and charges the operator a fee.

Each of these works only if the separate company is a real business with arm's-length pricing, its own books, and no share in the sale of product. The Tax Court has applied 280E to a "management company" whose employees handled the dispensary's marijuana sales (Alternative Health Care Advocates v. Commissioner, 151 T.C. 225 (2018)), and a company whose fee is a percentage of cannabis revenue risks being treated as trafficking itself. Florida's vertically integrated licensing model, where one licensee cultivates, processes, and dispenses, limits how far an operator can split functions, but real estate and intellectual property separation remains available. For a Florida treatment center outside 280E from 2026, these companies lose their 280E purpose — the operator deducts the rent, lease payments, royalties, and fees itself — though they can still serve liability, financing, and estate-planning goals.

Licensing constraints on ownership

State licenses are issued to specific entities and owners after background checks, and changes in ownership above a threshold require regulator approval. That constrains the entity: investors cannot simply buy in, estate transfers need regulatory sign-off, and the buy-sell agreement must contemplate a successor the state will license. In Florida, the small number of licenses and their value make the license-holding entity's structure a matter of corporate and regulatory counsel as much as tax. Since April 28, 2026, a state medical licensee can also apply for federal DEA registration through an expedited process that treats its state license as conclusive evidence of state authorization.

Estimated taxes on phantom income

Under 280E, a pass-through operator's owners owe estimated taxes on their share of gross profit, four times a year, regardless of distributions; a dispensary with cash profit of $500,000 and taxable income of $1.5 million must distribute enough to cover tax on the larger figure — at the 37 percent top rate, up to about $555,000, more than its entire cash profit. A C corporation owes corporate estimates on the same inflated income — the safe harbor based on prior-year tax protects against penalties but not against the cash drain, and a corporation with taxable income of $1 million or more in any of the three prior years can use that safe harbor only for its first installment. Either way, the tax reserve is a fixed percentage of gross profit, not of cash profit, set aside monthly. Operators that run short find the IRS has its full collection powers and no special relief for 280E hardship. A medical licensee that sized its 2026 estimates on a 280E base can, under the planned transition rule, size its remaining installments on ordinary taxable income and recover any overpayment on its return — a judgment to make with an adviser until the guidance is issued.

State fees, excise taxes, and conformity

License application and renewal fees — for a Florida treatment center, a $146,000 application fee in the most recent licensing round and a two-year renewal fee of $1,340,383.11 for renewals due in 2025 and 2026 — are not deductible for an operator under 280E; for a medical licensee outside the rule from 2026, they are ordinary business costs again. States with adult-use programs impose excise taxes on sales, collected by the retailer and remitted — a liability in the books, not revenue — and several have decoupled their income tax from 280E, allowing state deductions. Florida has not, so its corporate income tax follows the federal result in both directions.

The rescheduling question

A final order effective April 28, 2026, placed in Schedule III marijuana in FDA-approved drug products and marijuana subject to a state medical marijuana license, leaving all other marijuana — adult-use sales included — in Schedule I. Section 280E applies only to Schedule I and II substances, so state medical licensees fall outside it. Treasury and the IRS have announced guidance with a transition rule under which the change generally first applies for a business's full taxable year that includes April 28, 2026 — all of 2026 for a calendar-year business — and with rules for apportioning expenses when a business has both medical and adult-use activity; as of early October 2026 that guidance had not been issued. Earlier years stay under 280E. The broader proposal to move all marijuana to Schedule III, published by the Drug Enforcement Administration in May 2024, went to a DEA hearing in June and July 2026 and remains pending; court challenges to the April order are also pending, though the order remains in effect. Until that broader rule takes effect, adult-use operators plan under 280E; a structure built for 280E remains sound if the rule falls away, with the C corporation question revisited at that point — as Florida's medical operators are now doing.

Worked example. A Florida treatment center operator with $12 million of sales and $4 million of cash profit had taxable income under 280E of $7 million after inventory costs for 2025. As a C corporation it paid about $1.47 million federal and $382,000 Florida tax — nearly half its cash profit — and retained the rest. Had it been an S corporation, its three owners would have reported $7 million of pass-through income at up to 37 percent, owing roughly $2.6 million on $4 million of cash. If 2026 repeats those numbers, the planned transition rule puts the whole year outside 280E: taxable income falls to about $4 million, federal tax to $840,000, and Florida tax to about $217,000 — roughly 26 percent of cash profit — while S corporation owners would owe up to about $1.48 million at 37 percent, before any qualified business income deduction. The owners hold the cultivation facility in an LLC leased to the operator at $900,000 a year and the brand in a licensing company receiving $300,000 of royalties; both deduct their own expenses, and from 2026 the operator deducts the rent and royalties as well. Its corporate estimates had been paid quarterly from a reserve of about 27 percent of gross profit — the combined federal and Florida rate on a 280E base; under the planned transition rule, the remaining 2026 installments can be sized on the smaller base.

Official sources

The IRS explains: “Cash payment options are available for unbanked taxpayers. Some IRS Taxpayer Assistance Centers accept cash.” — Internal Revenue Service, Cannabis industry, https://www.irs.gov/businesses/small-businesses-self-employed/cannabis-industry

The Treasury Department explains: “Guidance is also expected to include a transition rule providing that, for purposes of section 280E, rescheduling generally will be considered to first apply for a business’s full taxable year that includes the effective date of the Final Order, for the business’s activities that do not involve Schedule I or II controlled substances as a result of the Final Order.” — U.S. Department of the Treasury, Treasury, IRS Announce Process for Tax Guidance Following DOJ Final Order on Medical Marijuana Rescheduling, https://home.treasury.gov/news/press-releases/sb0471

The rescheduling order states: “Namely, I am hereby ordering that FDA-approved drug products containing marijuana, as well marijuana in any form covered by a state medical marijuana license, be placed in schedule III of the CSA.” — Drug Enforcement Administration, Schedules of Controlled Substances: Rescheduling of Food and Drug Administration Approved Products Containing Marijuana From Schedule I to Schedule III; Corresponding Change to Permit Requirements, https://www.federalregister.gov/documents/2026/04/28/2026-08176/schedules-of-controlled-substances-rescheduling-of-food-and-drug-administration-approved-products

Related guides

• Cannabis Business Taxes: Section 280E, the Cost of Goods Sold That Survives It, and the Ancillary Company That Escapes It
• When a C Corporation Beats an S Corporation
• Holding Companies and Multiple LLCs: Does the Structure Pay?
• Two Penalty Taxes on C Corporations That Keep Cash
• Economic Substance: When a Tax Strategy Has No Substance

Next step

Fairlight Accounting handles U.S. domestic, cross-border (U.S.–Canada), and international tax returns, plus bookkeeping, payroll, and CFO advisory. Our U.S. Tax Desk models the C and S results on 280E income and structures the companies that sit outside it with the substance they need. See pricing or book a free fit call.